These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2572256)
21. Xamoterol in mild to moderate heart failure: a subgroup analysis of patients with cardiomegaly but no concomitant angina pectoris. European 'Corwin' Study Group Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):67S-69S. PubMed ID: 2572258 [TBL] [Abstract][Full Text] [Related]
22. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure]. Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820 [No Abstract] [Full Text] [Related]
23. Xamoterol versus digoxin in heart failure. Lancet; 1988 Apr; 1(8590):877. PubMed ID: 2895376 [No Abstract] [Full Text] [Related]
24. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol. Erlemeier HH; Kupper W; Bleifeld W Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349 [TBL] [Abstract][Full Text] [Related]
25. Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group. Lancet; 1990 Jul; 336(8706):1-6. PubMed ID: 1694945 [TBL] [Abstract][Full Text] [Related]
26. Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol. Vigholt-Sørensen E; Faergeman O Br Heart J; 1990 Sep; 64(3):186-9. PubMed ID: 1976339 [TBL] [Abstract][Full Text] [Related]
27. The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure. Francis GS Am Heart J; 1989 Sep; 118(3):642-8. PubMed ID: 2570521 [TBL] [Abstract][Full Text] [Related]
28. Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol. Erlemeier HH; Kupper W; Bleifeld W Int J Cardiol; 1990 Aug; 28(2):197-208. PubMed ID: 1697569 [TBL] [Abstract][Full Text] [Related]
29. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group. Lancet; 1988 Mar; 1(8584):489-93. PubMed ID: 2893916 [TBL] [Abstract][Full Text] [Related]
30. Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle. Vigholt-Sørensen E; Faergeman O; Snow HM Br Heart J; 1989 Nov; 62(5):335-41. PubMed ID: 2574049 [TBL] [Abstract][Full Text] [Related]
31. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial. de Feyter PJ; Serruys PW; Suryapranata H Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562 [TBL] [Abstract][Full Text] [Related]
32. Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group. Waller DG; Webster J; Sykes CA; Bhalla KK; Wray R Eur Heart J; 1989 Nov; 10(11):1003-10. PubMed ID: 2574108 [TBL] [Abstract][Full Text] [Related]
33. Xamoterol monotherapy in heart failure. The European 'Corwin' Group. Timewell RM; Stark RD; Marlow HF Eur Heart J; 1990 Apr; 11 Suppl A():62-4. PubMed ID: 1971596 [TBL] [Abstract][Full Text] [Related]